Abstract) The!target)population!is!healthcare!personnel!in!primary!care!and!medical!specialty!clinics.!

Similar documents
ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults

RHCs in Accountable Care Organizations (ACOs)

Geriatrics and Extended Care Goal-Oriented Shared Decision Making Initiatives for Veterans

Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania

Streptococcus pneumoniae CDC

Veterans Health Administration Lung Cancer Screening Demonstration Project: Results & Lessons Learned

Reaching Out Model Programs Fact Sheet

Joint Commission 2010 Guidelines: Influenza Vaccinations for Health-Care Workers

the benefits and potential side effects of pneumococcal immunization; and

Registered Nurses and Influenza Vaccination: Changing Mindsets and Improving Compliance to Foster Global Health

Jon Temte, MD/PhD Chair Wisconsin Council on Immunization Practices Professor of Family Medicine and Community Health

New England healthcare providers perceptions, knowledge and practices regarding the use of antiretrovirals for prevention

Getting national guidelines into practice: It takes more than education

Performance Measures for Adult Immunization

globally. Public health interventions to improve maternal and child health outcomes in India

INFLUENZA & PNEUMOCCOCAL VACCINATIONS

Session 2 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

Moving Healthcare Toward Greater Focus on Prevention

This evaluation was funded by the Centers for Disease Control and Prevention

Questions and Answers on 2009 H1N1 Vaccine Financing

LEVEL OF CARE GUIDELINES: PEER SUPPORT SERVICES OPTUM IDAHO MEDICAID

Adult Provider Visits. Adult Immunizations and New York State Immunization Superheroes

Accredited Provider: Educational Collaborators: Leading Age Indiana P.O. Box Indianapolis, IN

Executive Summary. Introduction to the Community Profile Report

Session 2 THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

TRUE Hospice Utilization Project Hospice Access Research References

Pfizer Medical Education Group Request for Proposals (RFP) Rheumatoid Arthritis Appropriate Immunizations in RA Patients

Effectiveness of rotavirus vaccination Generic study protocol for retrospective case control studies based on computerised databases

Measure #111 (NQF 0043): Pneumococcal Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health

2018 CMS Web Interface

Lessons Learned from HPV Vaccine Study Among Young Adult Women and Men

Table 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46)

ACIP Meeting Update, New Recommendations and Pending Influenza Season

Calaveras County TRL Evaluation Reporting Plan

Utilization of Skilled Maternity Personnel in Wa Ethnic Group in Hopang Township, Northern Shan State, Myanmar

Recommendations for Using Pneumococcal Vaccines among Adults

FAQs about Changes to DHR Immunization Rules and Regulations

Adult Immunization Rates

Assessing Clinic-Level Factors that Impact Viral Load Suppression

ACIP Recommendations for Adult Pneumococcal Immunization: Helping Pharmacists Assess, Recommend, Administer or Refer. Interim Outcomes Report

Mapping A Pathway For Embedding A Strengths-Based Approach In Public Health. By Resiliency Initiatives and Ontario Public Health

2014 Healthy Community Study Executive Summary

Vaccines for Primary Care Pneumococcal, Shingles, Pertussis

UPDATE ON IMMUNIZATION GUIDELINES AND PRACTICES

Recommendations for Using Pneumococcal Vaccines among Adults

NIH Public Access Author Manuscript Prev Med. Author manuscript; available in PMC 2014 June 05.

September 14, All Medical Providers and Health Care Facilities. NYSDOH Bureau of Immunization

Title of Project: Improving Adult Vaccination Practices. Principal Investigator and Team Members:

Sample Evaluation Plan. Indicator 3.2.7

COMMUNITY PROFILE REPORT. Susan G. Komen for the Cure Greater Cincinnati Affiliate

Designing an Electronic Medical Record-based Clinical Decision Support Tool to Improve CVD Screening in Rheumatoid Arthritis Patients

Addressing the Opioid Epidemic in the Veterans Health Administration

Innovation in the Oral Health Service Delivery System

Vaccines in Immunocompromised hosts

PQA Measure Development Update: June 2017

Organizational HIV Treatment Cascade Guidance for Construction. Introduction. Background

Part 1: The Rationale for Sentinel Surveillance to Monitor Seasonal and Pandemic Influenza

To view past issues, go to: The New 13-Valent Pneumococcal Conjugate Vaccine (PCV13)

2007 ACIP Recommendations for Influenza Vaccine. Anthony Fiore, MD, MPH Influenza Division, NCIRD, CDC

California Vaccines for Adults (VFA) Program - Year 2 Program Requirements -

North Dakota Dentists Survey Results Health Profession Tracking Program

Quantitative OR methodologies I

MEDICAL ASSISTANCE BULLETIN

Modular Program Report

Measure #111 (NQF 0043): Pneumonia Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health

Fulton County Board of Health Strategy to End the HIV Epidemic in Fulton County

Keywords health care services, gestation, rural communities, awareness

Healthcare Personnel Safety Component. Healthcare Personnel Vaccination Module Influenza Vaccination Summary. Outpatient Dialysis Facilities

Healthcare Personnel Immunization Recommendations

HealthVoices. Health and Healthcare in Rural Georgia. The perspective of rural Georgians

Health Care Worker Vaccination 2011 Texas

Data: Access, Sources, and Systems

Questions and Answers for Health Care Worker (HCW) Influenza Immunization Coverage Reporting by Ontario Hospitals and Long-Term Care Homes (LTCHs)

About the Highmark Foundation

Building Clinical Capacity about ASD and other Neurodevelopmental Disabilities among Rural Providers

Pfizer Independent Grants for Learning & Change Request for Proposals (RFP) Rheumatoid Arthritis Mono- and Combination DMARD Therapy in RA Patients

COMMUNITY PROFILE REPORT 2011 Northeast Ohio Affiliate of Susan G. Komen for the Cure

Working Document on Monitoring and Evaluating of National ART Programmes in the Rapid Scale-up to 3 by 5

Clinical Video Teleconferencing Into the Home: SC Rural Access to Veterans Health Resources

January 17, Re: Secretary s Advisory Committee on National Health Promotion and Disease Prevention Objectives for Healthy People 2030

Final Outcomes Report

RxVACCINATE: A National Education and Practice Support Initiative to Increase Pharmacist Administered Pneumococcal Vaccinations.

Flu & Pneumonia Provider Toolkit

Changes for the School Year

Call for Proposals: Demonstration Projects and Champion Development for Providers to address Type 2 Diabetes Prevention

Evaluating Awareness of Pneumococcal Vaccination Among Adults 65 Years Old and Above Attending a SingHealth Polyclinic A Community Health Study

Community Health Improvement Plan

Evaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK

Health disparities are linked to poor birth outcomes in Memphis and Shelby County.

Series of 2 doses, 6-12 months apart. One dose is 720 Elu/0.5ml (GSK) or 25 u/0.5 ml (Merck)

5/26/2016 BEXAR TAB REMEMBERS TRANSLATIONAL ADVISORY BOARD ABOUT THE BEXAR TAB BEXAR COUNTY TAB: CHALLENGES & SUCCESSES

The ENRICH Study Evaluating an Innovative Approach to Increasing Use of Isoniazid Preventive Therapy to Prevent TB among People Living with HIV

Superior Immune Response to Protein-conjugate vs. Free Pneumococcal. Polysaccharide Vaccine in COPD. for the COPD Clinical Research Network

L.J Tan, MS, PhD Immunization Action Coalition Chief Strategy Officer THIS INITIATIVE IS BEING SUPPORTED BY A SPONSORSHIP FROM PFIZER

January 2, Dear Technical Review Committee Members:

2018 Healthy Aging Summit- Call for Abstracts

Incidence per 100,000

UHC. Moving toward. Ghana NATIONAL INITIATIVES, KEY CHALLENGES, AND THE ROLE OF COLLABORATIVE ACTIVITIES. Public Disclosure Authorized

SUSAN G. KOMEN NORTHEAST LOUISIANA EXECUTIVE SUMMARY

RESULTS OF A STUDY ON IMMUNIZATION PERFORMANCE

Transcription:

LouisStokesClevelandVAMedicalCenter LouisStokesClevelandDepartmentofVeteransAffairsMedicalCenter Reducingdisparitiesinpneumococcalvaccinationsrelatedtogeographyandtoprovider performancewithintheveteranshealthadministrationofohio PfizerLearningandChangeGrants:DisparitiesinAdultImmunizations Abstract The Advisory Committee on Immunization Practices (ACIP now recommends using the 13O valentpolysaccharideoproteinconjugatevaccine(pcv13foradultswithimmunesuppression. ACIPcontinuestorecommendthe23OvalentunOconjugatedpolysaccharidevaccine(PPSV23for people with chronic illness or age 65. The Veterans Administration(VA responded to this new element of complexity in pneumococcal vaccination by developing a national electronic clinicalremindergearedtowardsoutpatientclinicencounters. Theoverallgoalforthisprojectistosupporteffectiveimplementationanduseoftheelectronic clinicalremindertoincreasepneumococcalimmunizationsamongeligibleveteranswithinthe VeteransIntegratedServiceNetwork(VISNO10. Thetargetpopulationishealthcarepersonnelinprimarycareandmedicalspecialtyclinics. Thekeyobjectivesfortheprojectare: 1. ToquantifydisparitiesinpneumococcalvaccinationrateswithinVISNO10. 2. To determine barriers to use of the pneumococcal vaccine electronic clinical reminder withinnortheastohio. 3. To optimize the impact of the pneumococcal vaccine electronic clinical reminder throughaneducationalinterventionforprovidersinnortheastohio OutcomesevaluationincludesmeasuringpneumococcalimmunizationratesforOhioveterans, assessingbarrierstouseoftheelectronicclinicalreminderasreportedbyhealthcareproviders and developing an educational intervention that will permit providers to overcome those barriers. This application aligns with the focus of the Pfizer Learning and Change Grants on increasingimmunizationagainstpneumococcaldiseasesandsupportstheva sgoaltodeliver thehighestqualityhealthcaretoournation sveterans,includingthroughdiseaseprevention. i

LouisStokesClevelandVAMedicalCenter TableofContents OVERALLGOAL&OBJECTIVES...1 TECHNICALAPPROACH...2 A.CURRENTASSESSMENTOFNEED...2 I.BASELINEDATASUMMARY...2 II.TARGETAUDIENCE&BENEFICIARIES...5 B.PROJECTDESIGN&METHODS...5 FIGURE3...6 KEYOBJECTIVE1...6 KEYOBJECTIVE2...8 KEYOBJECTIVE3...9 C.EVALUATIONDESIGN(TABLE3...11 DETAILEDWORKPLAN...12 DELIVERABLESSCHEDULE(TABLE4...13 ii

LouisStokesClevelandVAMedicalCenter Reducingdisparitiesinpneumococcalvaccinationsrelatedtogeographyandtoprovider performancewithintheveteranshealthadministrationofohio OverallGoal&Objectives The Advisory Committee on Immunization Practices (ACIP recently modified pneumococcal vaccination strategies, recommending the novel, more immunogenic polysaccharidefprotein conjugate vaccine against 13 pneumococcal serotypes (PCV13 for adults with immune suppression.acipcontinuestorecommendtheunfconjugatedpolysaccharidevaccineagainst 23pneumococcalserotypes(PPSV23forpeoplewithchronicillnessorage 65. The Veterans Health Administration (VA, the largest integrated healthcare system in the United States, responded to this new element of complexity in pneumococcal vaccination by developinganationalelectronicclinicalremindergearedtowardsoutpatientclinicencounters. ThereminderwilldeploythroughouttheVeteransIntegratedServiceNetwork(VISNF10,which serves most of Ohio, by the fall of 2014. VISNF10 contains 31 communityfbased outpatient clinics(cbocswhichofferprimarycareinpredominantlyruralsettingswhile4medicalcenters and 2 multifspecialty outpatient clinics offer both primary and specialty care clinics in predominantlyurbansettings.ineachoftheseclinics,providerswithdifferentlevelsoftraining (physicians,advancedpracticenurses,physicianassistants,pharmacists,registerednursesand licensed practical nurses may be responsible for distinct aspects of patient care. Northeast Ohio,whichserves105,000uniqueveteransfrom24countieseachyear,ishometo13CBOCs including1multifspecialtyoutpatientclinicandthelouisstokesclevelandvamedicalcenter,a tertiaryfcarehospital. Theoverallgoalforthisprojectistosupportimplementationanduseoftheelectronicclinical reminderasameanstoincreaseimmunizationsagainstpneumococcaldiseaseamongeligible veterans.ourkeyobjectivestoachievethisgoalare: 1. To quantify disparities in pneumococcal vaccination rates for veterans in VISNF10 by wheretheyreside(ruralorurbansettingandbytheclinicalservicestheyuse(primary care,specialtycareorboth. 2. TodeterminebarrierstousingpneumococcalvaccineclinicalreminderwithinNortheast Ohiobygeographicsetting,servicesofferedandproviders typeoftraining. 3. To optimize the impact of the pneumococcal vaccine electronic clinical reminder throughaneducationalinterventionforprovidersinnortheastohio. ThegoalofthisapplicationalignswiththefocusofthePfizerLearningandChangeGrantson increasingimmunizationagainstpneumococcaldiseasesintheatfriskadultpopulation.italso contributestotheva sgoaltodeliverthehighestqualityandsafesthealthcaretoournation s veterans,includingthroughdiseaseprevention.finally,theoutcomesfromthekeyobjectives proposed here may be widely disseminated to support effective use of the pneumococcal immunizationelectronicclinicalreminderthroughoutthevahealthcaresystem. 1

LouisStokesClevelandVAMedicalCenter TechnicalApproach A. CurrentAssessmentofNeed i. BaselineDataSummary Pneumococcal*Vaccination*Rates*for*Veterans*in*VISN510* ** WeexaminedvaccinationratesforoutpatientsservedwithinVISNF10usingdataaccessedfrom the Data Warehouse, a data repository regularly updated with information from the Computerized Patient Record System (CPRS, the VA s longfstanding and robust electronic medicalrecordsystem.toestimatetheoverallrateofvaccination,wecalculatedthenumber ofindividuals whoreceivedanypneumococcalvaccinationamongthoseveteranswhohadat least1outpatientvisitinthe10fyearspanbetween2004and2013.whilethisestimationdoes not consider the eligibility of the individual veterans, it does offer a crude estimate of an overall pneumococcal vaccination rate within VISNP10 of about 21%.Thereislittlevariation amongthe4vamedicalcenters(vamcsorcolumbusoutpatientclinics. PPSV23representsvirtuallyallofthepneumococcalvaccinationsadministeredduringthistime (99.7%.ForthoseveteranswhoreceivedaseconddoseofPPSV23between2004 2013(n= 6588, the time between those doses met the recommended guidelines (>5 years for only ~50%ofcases.ForthosewhoreceivedtheirPPSV23doseearly,themeandurationbetween doseswas~2years(interquartilerangeof92 1283days.EvenpriortotheadventofPCV13, the majority of veterans administered a 2 nd dose of PPSV23 did not receive that dose in accordancewiththerecommendedpneumococcalvaccineschedule. InOctober2012,ACIPrecommendedroutineuseofPCV13foradultsaged 19yearswithan array of immune compromising conditions. In response to this change, the VA initiated developmentofanelectronicclinicalreminderthatincorporatedbothppsv23andpcv13with theintenttoofferguidancegiventhecomplexityoftherecommendationsaswellasoftheva patientpopulation.theelectronicclinicalreminderidentifiesthoseveteranswhoareeligible for PCV13, including in that cohort those who are immunocompromised,those who receive chemotherapy, immunosuppressive medications or longfterm steroids and those with a cochlearimplantorcerebrospinalfluidleak.italsoevaluatesforadministrationofppsv23in 2

LouisStokesClevelandVAMedicalCenter thepreviousyearandcontraindicationstopcv13.forthosewhohavealreadyreceivedorare noteligibleforpcv13,theelectronicclinicalreminderassessestheireligibilityforppsv23using similar parameters and also accounts for administration of a second dose based on patients ageandmedicaldiagnoses. The Dayton VAMC became a test site for the pneumococcal vaccine electronic clinical reminder, the first version of which was released in July 2013. Subsequently, therateofindividualswho received pneumococcal vaccines at the Dayton VAMC nearly doubled, increasing from 4.6% to 8.3%, while remaining unchanged in the other VAMCs within VISNF10. These data demonstrate the effectiveness of using the electronic medical record as a means to improve provider performance and patientvaccinationrates. Pneumococcal*Vaccination*Rates*for*HIV5Positive*Veterans*in*VISN510* Inadditiontoexaminingtheoverallpneumococcalvaccinationratesateachmedicalcenter,we also examined the proportion of pneumococcal vaccination among veterans with HIV, who accessthemajorityoftheirroutinemedicalcarethroughaninfectiousdiseasespecialtyclinic. TheproportionofthosewhoreceivedanypneumococcalvaccinationamongveteranswithHIV who had at least 1 outpatient visit in the 10Fyear span between 2004 and 2013 is 40%. FollowinginclusionofPCV13intheVAFormularyinApril,2013,therateofimmunizationsfor HIVFpositiveveteransincreasednearly2FfoldattheClevelandVAMC(17%to30%andover3F fold at the Cincinnati VAMC (23% to 78%. For both institutions, PCV13administration, consistent with the ACIP recommendations, drove this increase.interestingly, the rate of vaccination for HIVFpositive veterans at the Dayton VAMC did notchange. 3

LouisStokesClevelandVAMedicalCenter These data illustrate 3 points.first,despitebeing atestsitefortheelectronic clinical reminder, rates of pneumococcal immunization among HIV patients at the Dayton VAMC remain suboptimal. Indeed,in2013,ofthe164 HIV patients who had an ambulatory visit with their provider in Dayton VAMC, none received PCV13. Second, there is marked geographic variation in the rates of pneumococcal vaccinationforhivpatients between the 4 VAMCs and outpatient specialty clinics incolumbus,despitethese allbeingvafacilitieswithin a single VISN. Finally, the overall rate of pneumococcal vaccination amongvisnf10veteranslivingwithhivisquitelow.thisisespeciallyalarminggiventhathiv providers are usually attuned to encouraging vaccinations, particularly among immunocompromised adults. These findings underscore a need to educate providers in specialtyclinicstousetheelectronicclinicalreminderasameanstoimprovepneumococcal vaccinationcoverageamongourmorevulnerableveterans. 4

LouisStokesClevelandVAMedicalCenter ii. TargetAudience&Beneficiaries Ourinitialevaluationofdisparitiesinpneumococcalvaccinationwillincludethe4VAMCs,their affiliated CBOCs and the Columbus outpatient clinics. To assess barriers to using the pneumococcalvaccineclinicalreminder,wewilltargetthemultifdisciplinarygroupofproviders (physicians,advancedpracticenurses,physiciansassistants,pharmacistsandregisterednurses who serve the 105,000 veterans within the Northeast Ohio region that comprises the catchmentareaforthelouisstokesclevelandvamc.wewillincludeprovidersfromprimary careclinicsinrural(n=8andurban(n=5settingsaswellasthosefromspecialtyclinicsatthe Parma CBOC and at the main campus of the Cleveland VAMC. Providers targeted to receive educationandtrainingintheelectronicclinicalreminderwillcomefromthiscohort. WeanticipatethatboththeprovidersandespeciallytheveteransfromNortheastOhiowillbe immediate beneficiaries of the work proposed. Specifically, as providers knowledge and familiaritywithpneumococcalvaccinationstrategiesincreases,theirpatientswillbenefitfrom pneumococcalvaccineadministration.furthermore,theoutcomesoftheworkproposedhere will be shared with other facilities within VISNF10 as well as with the Veterans Health AdministrationNationalCenterforHealthPromotionandDiseasePrevention.Thiswillsupport further refinements in the electronic clinical reminder for pneumococcal vaccination. It may alsoofferspecificstrategiesfortargetededucationandtrainingofprovidersthroughouttheva Healthcaresystem. B.ProjectDesignandMethods Overview: The overall goal for this project is to support implementation and use of the electronic clinical reminder as a means to increase immunizations against pneumococcal diseaseamongeligibleveterans.toachievethis,weproposefirsttodeterminewhichveteran populationsweremostunderservedpriortoimplementationoftheelectronicclinicalreminder (Key Objective 1. We will also ascertain perceptions regarding use of the electronic clinical reminderbyproviderscaringforveteransinnortheastohio(keyobjective2.theoutcomes fromkeyobjective2willinformthedevelopmentofaneducationalinterventiondesignedto optimizeuseoftheelectronicclinicalreminder.outcomesfromkeyobjective1willidentify the type and location of clinics that would most benefit from implementation of the educationalintervention.designandimplementationoftheeducationalinterventioncomprise KeyObjective3(Figure3. 5

LouisStokesClevelandVAMedicalCenter KeyObjective1:Toquantifydisparitiesinpneumococcalvaccinationratesfor veterans in VISNP10 by where they reside(rural or urban setting and by the clinicalservicestheyuse(primarycare,specialtycareorboth. Purpose/Hypothesis:ToaccessprimarycarewithintheVAhealthcaresystem,veteransusually attendthecbocmostconvenienttotheirhome,whichmaybeinanurbanorruralsetting.we hypothesizethatveteranswithinvisnp10whoattendprimarycareclinicsinruralareashave lower pneumococcal vaccination rates than veterans attending clinics in urban areas. Furthermore, veterans with chronic health conditions, such as HIVFinfection, rheumatoid arthritisorcancermaysupplantprimarycareinfavorofaspecialtyclinic,regardlessofwhether they live in an urban or rural setting. As they focus on patients chronic health problems, specialty providers may overlook health maintenance, including routine immunizations. We further hypothesize that veterans seen mostly by primary care providers have higher pneumococcal vaccination rates than veterans seen mostly by specialist providers (e.g., infectiousdiseases,rheumatology,oncologyetc.. 6

LouisStokesClevelandVAMedicalCenter Methods:Totestourhypotheses,wewillconductaretrospectivecohortstudyontheveterans with VISNF10 who had at least one outpatient clinic visit per year for two consecutive years between2004and2013.wewillquantifypneumococcalvaccinationratesbasedon (i (ii whetherveteransresideinanurbanorruralsettingand, whether the veteran receives the majority of their care from a primary care provider,specialistorboth. DataCollection&Analysis:WewillobtaindatafromtheVISNF10DataWarehousesearchable under a structured query language (SQL environment. Updated from the Computerized PatientRecordSystem(CPRSeachnight,theDataWarehousemaintainsupFtoFdateandvalid data.patientseligibleforimmunizationwithppsv23andpcv13willbeidentifiedaccordingto age (>65 and ICDF9 codes designating chronic illnesses and immune suppressive conditions. Additional data will include patient demographics, county of residence, diagnoses by ICDF9 code, the number of outpatient visits/year categorized by types of services accessed and immunizationhistory. WewillcharacterizepatientseligibleforPCV13andPPSV23vaccinesandestablishtheratesof vaccinationinthosegroups.theprimaryindependentvariableswillbepatients residencein an urban vs.* rural county (determined using the National Center for Health Statistic 2013 UrbanFRural classification scheme 1 and patients utilization of primary care and medical specialty clinics. We will use multivariable logistic regression to determine associations between pneumococcal vaccination status and the independent variables after adjusting for thepotentiallyconfoundingeffectsofcovariates. AnticipatedOutcomes:Weanticipatethatjustaswiththegeneralpopulation,veteransliving inruralenvironmentswillhavelowervaccinationratescomparedtothoselivinginurbanareas. Wefurtheranticipatethattheoverallrateofvaccinationamongthoseeligiblebasedonchronic health conditions will be lower among those eligible based upon age. We also expect that, regardlessoftheiruseofspecialtyclinics,veteranswhohavelessthan1primarycarevisiteach year(averagedover5yearswillhavereducedpneumococcalvaccinationcoverage. Pitfalls and Limitations: Some veterans choose to access medical care outside of the VA system.shouldtheyreceivepneumococcalimmunizationsbyanonfvaprovider,itwillnotbe reflectedincprsandwemayunderestimatepneumococcalcoverageinourpopulation. TheneedaddressedObjective1istoquantifydisparitiesinvaccineadministrationbetween ruralandurbanlocations,andbetweenprimarycareandspecialtyproviders,bycomparing vaccinationratesamongthosegroups.thedesiredresultswillbeobtainedbyutilizingthe rich, detailed and comprehensive data set available at the VA, and by determining associationsandcontrollingforimportantcovariates.theseresultswillidentifylocationsand types of providers where barriers to the use of the electronic clinical reminder are critical, andthatwouldmostbenefitmostfromaninterventiontooptimizeitsuse. 7

LouisStokesClevelandVAMedicalCenter Key Objective 2: To determine barriers to use of the pneumococcal vaccine electronic clinical reminder within Northeast Ohio, by geographic setting, servicesoffered,andproviders typeoftraining. Purpose/Hypothesis: The purpose of this work is to evaluate the barriers perceived to the implementation of the electronic clinical reminder perceived by healthcare providers. As summarized in this grant s request for applications, known barriers to pneumococcal vaccination among healthcare providers include lack of awareness about ACIP guidelines, not eliciting an immunization history, skepticism towards vaccinations, not considering it their responsibility and lack of continuity. Systems barriers include lack of an structure ensuring vaccinationandinadequatesupplies.itisunclear,however,whatbarriersmaylimittheuseof electronic clinical reminders intended to improve vaccination practices. We hypothesize that there are barriers to pneumococcal vaccination that specifically arise from the design and contentoftheva selectronicclinicalreminder. Methods:TheelectronicclinicalreminderisforecastfordisseminationthroughoutVISNF10in October,2014.BeginninginJanuary2015,wewilladministerananonymouselectronicsurvey to healthcare providers staffing the 5 urban and 8 rural CBOCS(community based outpatient clinics in Northeast Ohio as well as those who work in primary care and medical specialty clinics at the Cleveland VA medical center. Theproviderssurveyedwillinclude physicians, advanced practice nurses, physician assistants, pharmacists, registered nurses and licensed practical nurses. The survey questions will address participants knowledge, attitudes and beliefs regarding the efficacy, indications and contraindications to and perceived barriers to pneumococcal vaccination. The survey will also query their perceptions and experience with the pneumococcal vaccine electronic clinical reminder. Answers will conform to a LikertFlike scale. Drawingfromthissamepopulation,wewillalsoapplyamixedFmethodsapproach,andinvite healthcare providers to participate in semipstructured interviews. The primary goal of the interviews will be to elicit the perspective of healthcare providers on the acceptability and usefulness of the pneumococcal vaccine electronic clinical reminder. Secondary goals will assessparticipants knowledge,attitudesandbeliefsregarding:pneumococcaldiseaseburden; vaccine indications, contraindications and efficacy; potential adverse effects; and barriers to pneumococcalvaccination.interviewswillberecorded(audioonly. DataCollectionandAnalysis:Wewillcompareoutcomesoftheelectronicsurveybasedonthe respondents practice setting (urban or rural, type of training (physician, advanced practice nurse,physicianassistant,pharmacist,registerednurseandlicensedpracticalnurseandtype ofclinic(primarycareormedicalspecialtyusingananalysisofvariance(anova. Interviews will be conducted between January and June of 2015 at the participant s site of practice. Reoccurring ideas expressed by the participants will be grouped into themes; associationsbetweenthemeswillalsobeidentified. 8

LouisStokesClevelandVAMedicalCenter Anticipated Outcomes: From the electronic survey, we anticipate that, compared to subspecialists, primary care physicians and advanced practice nurses will have higher scores regarding knowledge of pneumococcal vaccine benefits and recent ACIP recommendations regarding PCV13.Furthermore, we expect that compared to registered nurses and license practical nurses, physicians and advance practice nurses will report greater barriers to use of the electronic clinical reminder, citing both time and patient complexity. We do not foresee notabledifferencesbasedontheclinicsetting(urbanorruralortypeofcareoffered(primary careormedicalspecialty. PitfallsandLimitations:Decreasedparticipationbyspecificgroupsofproviders(basedontheir practicelocation,serviceortypemaylimitinterpretationofsomeaspectsoftheresults. The need addressed by Objective 2 is to identify barriers to the use of the pneumococcal vaccine electronic clinical reminder. The desired results will be obtained by utilizing qualitativeanalysesthroughsurveysandinterviewsofhealthcareproviders.theinformation obtainedwillfacilitatethedesignofaneducationalinterventionintendedtoimprovetheuse oftheelectronicclinicalreminder. KeyObjective3:Tooptimizetheimpactofthepneumococcalvaccine electronicclinicalreminderthroughaneducationalinterventionforproviders innortheastohio. Purpose/Hypothesis: The purpose of these activities is to implement an educational intervention directed towards healthcare workers that complements and supports the use of theelectronicmedicalreminder.ourhypothesisisthataneducationalinterventiontailoredto addressthebarriersidentifiedinobjective2,willincreasetheimpactofanelectronicclinical reminder on pneumococcal vaccination rates. We will target this intervention clinics in Northeast Ohio that serve the veteran population most in need of improved pneumococcal vaccinecoverage,asdetermineinobjective1. Methods:AninFservicetrainingmodulewillbedevelopedanddeliveredtoVAprimarycareor medicalspecialtyclinicsinnortheastohioservingveteranpopulationsthatfallintothelowest quartileofpneumococcalvaccinationrates(objective1.thetrainingwillbeprovidedduringa monthly staff meeting and will include instructions on how to use the electronic clinical reminder, describe ACIP immunization recommendations, and present providers with an overview of pneumococcal disease and its burden. Importantly, the training module will specifically seek to overcome barriers to pneumococcal vaccination identified by Objective 2. The training module will emphasize content that addresses deficits in knowledge regarding pneumococcal vaccines, will acknowledge beliefs that lead providers and veterans to avoid pneumococcalvaccination,andwillattempttocounterpracticesthatleadtopooradherence toaciprecommendationsanddecreasedimmunizationrates.participantswillbeencouraged to complete an electronic survey, similar to the survey described in Objective 2, which also solicitsdirectedfeedbackabouttheeffectivenessoftheeducationalintervention. 9

LouisStokesClevelandVAMedicalCenter Data collection and analysis: Quantitative evaluation of the impact of the educational intervention will employ a pref/postfintervention design, measuring changes in vaccination rates in the clinic before and after the intervention. Data will be obtained from the VISNF10 DataWarehouseaccessiblethroughSQLqueries,asdescribedinObjective1.Also,changesin vaccination rates and use of the clinical reminder that occur in the clinics that receive the education and training module can be compared to those for clinics that did not receive the educationalintervention.scoresobtainedinthecomputerfbasedsurveybeforeandafterthe intervention will also be compared, for individual participants using paired tftest, as well as aggregatescoresforparticipatingclinics. Anticipated outcomes: We anticipate that the clinics involved with the educational intervention will demonstrate a significant increase in pneumococcal vaccination rates, comparedtoratesinthesameclinicbeforetheintervention,andtoclinicsthatdonotreceive theintervention.wealsoanticipateachangeintheknowledge,beliefs,andattitudestowards the electronic clinical reminder and pneumococcal vaccination among providers that receive theeducationalintervention.traininghealthcareprovidersontheuseoftheelectronicclinical reminderwillalsooffertheopportunitytoprovideupftofdateinformationaboutimmunization rateswithinvisnf10aswellastheirparticularunit.wepredictthatthisdirectfeedbackwill empower healthcare providers to commit to improving their clinic s performance for pneumococcalvaccination. Limitationsandpitfalls:Theresultsoftheinterventionwilllargelydependontheparticipation of healthcare providers. Substantial modifications to the electronic clinical reminder itself, to increaseitsfunctionalityandacceptability,arenotanticipatedatthisstage. The need addressed by Objective3 is to support the use of the electronic clinical reminder withatailorededucationalintervention.thedesiredresultswillbeobtainedbyincorporating providers perceived barriers to pneumococcal vaccination and the electronic clinical reminder into an educational intervention targeted to those clinics serving veteran populationsthatfallintothelowestquartileofpneumococcalvaccinationcoverage. 10

LouisStokesClevelandVAMedicalCenter C.EvaluationDesign Table3:EvaluationDesignofOutcomesfromKeyObjectives1P3 KeyObjective 1 To*quantify*disparities*in* pneumococcal* vaccination*rates*for* veterans*in*visn510*by* where*they*reside*and*by* the*clinical*services*they* use* 2 To*determine*barriers*to* using*pneumococcal* vaccine*clinical*reminder* within*northeast*ohio*by* geographic*setting,* services*offered*and* providers *type*of* training* Gap Addressed Whoneeds the program andhow greatisthe need Target population sopinions, knowledge, attitudes andbeliefs and perception ofbarriers Data Source VISNF10 Data Warehouse Guided interviews Surveyof healthcare providers Data Collection SQLQueries Interview WebFbased survey Analysis Vaccineeligibility Ratesofvaccination Residenceinanurbanvs.* ruralcounty Utilizationofprimary careormedicalspecialty clinics Multivariablelogistic regressionanalysis Systematicanalysisof content,conclusion drawingand verification ScoresinwebFbased surveyandassociations withlocationandtypeof practice ANOVA 3 To*optimize*the*impact*of* the*pneumococcal* vaccine*electronic*clinical* reminder*through*an* educational*intervention* for*providers*in*northeast* Ohio* Towhat extentis the program achieving its outcomes VISNF10 Data Warehouse Surveyof healthcare providers SQLQueries WebFbased survey Ratesofvaccination Surveyscoresand associationswith locationandtypeof practice PreFandpostF interventioncomparison; onegroupparticipatesin program,otherdoesnot Quantification*of*change:Weanticipatethatthetargetaudiencewillimprovetheirperception pneumococcal vaccination and of the electronic clinical reminder by 30%. We anticipate that the immunization rates in clinics that receive the intervention will increase by at least 30%, basedontheexperienceatdaytonva. Target*audience*engagement:Wewillhave1:1contactwithprovidersintheclinicsselectedfor theeducationandtrainingintervention.weplantoadministerapostfinterventionsurveyand assesstheirresponseandengagement. 11

Dissemination*of*outcomes:WeintendtoreportourfindingstotheleadersinVSINF10andVHA CentralOffice.Weplantosubmittoapeerreviewjournalamanuscriptdescribingbarriersto theuseoftheelectronicclinicalreminderanddisparitiesinpneumococcalvaccinationrates. DetailedWorkPlanandDeliverablesSchedule Objective* 1:* * The work proposed is to quantify the rates of pneumococcal vaccination for veteranswithinvisnf10overthe10fyearspanfrom2004 2013.Thisdataalreadyexistsin thedatawarehouse.thespecifictasksinvolvedinachievingobjective1aredetailedbelow, including the anticipated start and stop dates. 07/14 09/14 ExtractdatafromtheVISNF10Data 10/14 12/14 Datacleaningandvalidation 01/15 06/15 Analysisofvaccinationratesbycounty&clinictype Objective* 2: The goals are to conduct a qualitative assessment of health care providers experiences with the electronic clinical reminder, which is slated for implementation across VISNF10 by October, 2014. We intend for health care personnel to have at least 3 months experience with the electronic clinical reminder before initiating surveys about those experiences. 11/14 02/15 DevelopsemiFstructuredinterviewandelectronicsurvey 03/15 06/15 Enrollandconductinterviews Launchelectronicsurvey 07/15 12/15 Dataanalysis,identifyrecurringideas,themes Analyzedatafromelectronicsurvey Objective* 3: The goals are to improve the use of the electronic clinical reminder through an educationalintervention.theoutcomesfromaim2willinformthecontentoftheeducation regardingtheelectronicclinicalreminderwhiletheoutcomesfromaim1willinformtheclinics enrolled. 01/16 06/16 Develop,pilottesttheeducationalintervention 07/16 12/16 Implementtheeducationalintervention 01/17 12/17 *Measurechangesinpneumococcalcoveragein clinicsthatparticipatedineducationalintervention. *Thisanalysiswillextendbeyondtheproposedfundingperiod. * * LouisStokesClevelandVAMedicalCenter 12

LouisStokesClevelandVAMedicalCenter Table4:Detailed(Work(Plan(with(Schedule(for(Deliverables(and(Estimated(Costs((based(on(salary(support(of(involved(personnel( year(( 2014 2015 2016 2017 Personnel a Estimated Cost Deliverables( quarter( 3 4 1 2 3 4 1 2 3 4 KeyObjective1:((Quantitative(Assessment(of(Pneumococcal(Vaccination(in(VISNN10( ( ( (((((Pneumococcal(coverage(by(urban(vs.(rural(setting( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (((((Pneumococcal(coverage(by(use(of(primary(vs.(( (((((specialty(care(clinics KeyObjective2:((Qualitative(Assessment(of(Pneumococcal(Vaccine(Electronic(Clinical(Reminder( ( ( (((((Survey(of(personnel(working(in(primary(care(clinics( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( (((((Survey(of(personnel(working(in(medical(specialty( clinics KeyObjective3:Educational(Intervention(( ( ( Develop(educational(intervention( ( ( ( ( ( ( ( ( ( ( ( ((Implement(intervention( ( ( ( ( ( ( ( ( ( ( ( ((Study(effects(of(intervention( ( ( ( ( ( ( ( ( ( ( ( ( 13